National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 26539-26540 [2021-10150]
Download as PDF
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 92 / Friday, May 14, 2021 / Notices
26539
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders A Study Section.
Date: June 21–22, 2021.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Natalia Strunnikova,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS/Neuroscience
Center, 6001 Executive Blvd., Suite 3208,
MSC 9529, Rockville, MD 20852, (301) 402–
0288, natalia.strunnikova@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trial Readiness for
Rare Neurological and Neuromuscular
Diseases.
Date: June 21, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Neuroscience Center, 6001 Executive
Boulevard Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Ana Olariu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Room 3208, MSC 9529, Rockville, MD 20852,
(301) 496–9223, Ana.Olariu@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NINDS Diversity K01 and
K22 Application Review.
Date: June 23, 2021.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: William C. Benzing, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3204, MSC 9529, Rockville, MD 20852,
(301) 496–0660, benzingw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
Dated: May 10, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: May 11, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10158 Filed 5–13–21; 8:45 am]
[FR Doc. 2021–10220 Filed 5–13–21; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:58 May 13, 2021
Jkt 253001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Minority
Aging.
Date: June 29, 2021.
Time: 11:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Gateway Building, Suite 2W200, Bethesda,
MD 20892, (301) 480–1266 neuhuber@
ninds.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; MultiComponent Project.
Date: July 6, 2021.
Time: 1:00 p.m. to 5:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Dario Dieguez, Jr, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, Gateway Building, Suite
2W200, 7201 Wisconsin Avenue, Bethesda,
MD 20892, (301) 827–3101, dario.dieguez@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group; Arthritis and Musculoskeletal
and Skin Diseases Clinical Trials Review
Committee.
Date: June 3–4, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis,
Musculoskeletal and Skin Diseases, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Yin Liu, Ph.D., MD,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis and
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6701 Democracy Blvd.,
Room 824, Bethesda, MD 20817, 301–594–
8919, liuy@mail.nih.gov.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group; Arthritis and Musculoskeletal
and Skin Diseases Special Grants Review
Committee.
Date: June 24–25, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis,
Musculoskeletal and Skin Diseases, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Helen Lin, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Suite 800, Bethesda,
MD 20817, 301–594–4952, linh1@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
E:\FR\FM\14MYN1.SGM
14MYN1
26540
Federal Register / Vol. 86, No. 92 / Friday, May 14, 2021 / Notices
Dated: May 10, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10150 Filed 5–13–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
Extension of Agency Information
Collection Activity Under OMB Review:
Screening Partnership Program
Transportation Security
Administration, DHS.
ACTION: 30-Day notice.
AGENCY:
This notice announces that
the Transportation Security
Administration (TSA) has forwarded the
Information Collection Request (ICR),
Office of Management and Budget
(OMB) control number 1652–0064,
abstracted below to OMB for review and
approval of an extension of the
currently approved collection under the
Paperwork Reduction Act. The ICR
describes the nature of the information
collection and its expected burden. The
collection involves an application
completed by airports to initiate a
request to participate in TSA’s
Screening Partnership Program (SPP).
DATES: Send your comments by June 14,
2021. A comment to OMB is most
effective if OMB receives it within 30
days of publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under Review—Open for
Public Comments’’ and by using the
find function.
FOR FURTHER INFORMATION CONTACT:
Christina A. Walsh, TSA PRA Officer,
Information Technology (IT), TSA–11,
Transportation Security Administration,
6595 Springfield Center Drive,
Springfield, VA 20598–6011; telephone
(571) 227–2062; email TSAPRA@
tsa.dhs.gov.
SUPPLEMENTARY INFORMATION: TSA
published a Federal Register notice,
with a 60-day comment period soliciting
comments, of the following collection of
information on February 12, 2021. See
86 FR 9358.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
Comments Invited
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
VerDate Sep<11>2014
19:58 May 13, 2021
Jkt 253001
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a valid OMB control
number. This ICR documentation will
be available at https://www.reginfo.gov
upon its submission to OMB. Therefore,
in preparation for OMB review and
approval of the following information
collection, TSA is soliciting comments
to—
(1) Evaluate whether the proposed
information requirement is necessary for
the proper performance of the functions
of the agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including using
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Information Collection Requirement
Title: Screening Partnership Program
Application.
Type of Request: Extension.
OMB Control Number: 1652–0064.
Form(s): TSA Form 424 Screening
Partnership Program Application.
Affected Public: Airport Operators.
Abstract: Under 49 U.S.C. 44920, an
airport may submit an application to
TSA to have the screening of passengers
and property required by 49 U.S.C.
44901 conducted by non-Federal
personnel. TSA must approve the
application if the approval ‘‘would not
compromise security or detrimentally
affect the cost-efficiency or the
effectiveness of the screening of
passengers or property at the airport.’’
TSA implements this requirement
through the SPP. Participation in the
SPP is initiated with the application
covered by this information collection.
Number of Respondents: 2.
Estimated Annual Burden Hours: An
estimated 0.50 hours annually.
Dated: May 10, 2021.
Christina A. Walsh,
TSA Paperwork Reduction Act Officer,
Information Technology.
[FR Doc. 2021–10182 Filed 5–13–21; 8:45 am]
BILLING CODE 9110–05–P
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
[Docket No. TSA–2002–11602]
Intent To Request Extension From
OMB of One Current Public Collection
of Information: Security Programs for
Foreign Air Carriers
Transportation Security
Administration, DHS.
ACTION: 60-Day notice.
AGENCY:
The Transportation Security
Administration (TSA) invites public
comment on one currently approved
Information Collection Request (ICR),
Office of Management and Budget
(OMB) control number 1652–0005,
abstracted below that we will submit to
OMB for an extension in compliance
with the Paperwork Reduction Act. The
ICR describes the nature of the
information collection and its expected
burden. This information collection is
mandatory for foreign air carriers and
must be submitted prior to entry into
the United States.
DATES: Send your comments by July 13,
2021.
ADDRESSES: Comments may be emailed
to TSAPRA@tsa.dhs.gov or delivered to
the TSA PRA Officer, Information
Technology, TSA–11, Transportation
Security Administration, 6595
Springfield Center Drive, Springfield,
VA 20598–6011.
FOR FURTHER INFORMATION CONTACT:
Christina A. Walsh at the above address,
or by telephone (571) 227–2062.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Comments Invited
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a valid OMB control
number. The ICR documentation will be
available at https://www.reginfo.gov
upon its submission to OMB. Therefore,
in preparation for OMB review and
approval of the following information
collection, TSA is soliciting comments
to—
(1) Evaluate whether the proposed
information requirement is necessary for
the proper performance of the functions
of the agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
E:\FR\FM\14MYN1.SGM
14MYN1
Agencies
[Federal Register Volume 86, Number 92 (Friday, May 14, 2021)]
[Notices]
[Pages 26539-26540]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10150]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Arthritis and Musculoskeletal and Skin
Diseases Initial Review Group; Arthritis and Musculoskeletal and
Skin Diseases Clinical Trials Review Committee.
Date: June 3-4, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis, Musculoskeletal and Skin
Diseases, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Yin Liu, Ph.D., MD, Scientific Review Officer,
Scientific Review Branch, National Institute of Arthritis and
Musculoskeletal and Skin Diseases, National Institutes of Health,
6701 Democracy Blvd., Room 824, Bethesda, MD 20817, 301-594-8919,
[email protected].
Name of Committee: Arthritis and Musculoskeletal and Skin
Diseases Initial Review Group; Arthritis and Musculoskeletal and
Skin Diseases Special Grants Review Committee.
Date: June 24-25, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis, Musculoskeletal and Skin
Diseases, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Helen Lin, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Suite
800, Bethesda, MD 20817, 301-594-4952, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
[[Page 26540]]
Dated: May 10, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-10150 Filed 5-13-21; 8:45 am]
BILLING CODE 4140-01-P